Analysts fell to the sidelines weighing in on Cedar Fair (FUN – Research Report) and Medifast (MED – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Cedar Fair (FUN)
In a report released today, Barton Crockett from Rosenblatt Securities maintained a Hold rating on Cedar Fair, with a price target of $45.00. The company’s shares closed last Tuesday at $44.85.
According to TipRanks.com, Crockett is a 4-star analyst with an average return of
Cedar Fair has an analyst consensus of Moderate Buy, with a price target consensus of $53.43, representing a 19.1% upside. In a report issued on February 17, Credit Suisse also maintained a Hold rating on the stock with a $46.00 price target.
See the top stocks recommended by analysts >>
Medifast (MED)
D.A. Davidson analyst Linda Bolton Weiser maintained a Hold rating on Medifast today and set a price target of $94.00. The company’s shares closed last Tuesday at $105.44, close to its 52-week low of $96.00.
According to TipRanks.com, Weiser is a 4-star analyst with an average return of
Medifast has an analyst consensus of Hold, with a price target consensus of $94.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FUN:
- Cedar Fair price target raised to $61 from $54 at Deutsche Bank
- Cedar Fair price target raised to $57 from $50 at Stifel
- Amusement Park Offers Free Admission to All Current and Former Presidents of the United States of America
- Cedar Fair reports Q4 revenue $365.99M, consensus $345.76M
- Cedar Fair announces details for planned competitive gaming development
